We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+0.64%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$650M
AUM Growth
-$107M
Cap. Flow
-$73.7M
Cap. Flow %
-11.34%
Top 10 Hldgs %
28.5%
Holding
529
New
249
Increased
8
Reduced
22
Closed
155

Sector Composition

Rank Sector Weight
1 Healthcare 27.3%
2 Financials 11.86%
3 Technology 7.97%
4 Industrials 4.89%
5 Communication Services 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBEAU
176
DELISTED
SilverBox Engaged Merger Corp I Units
SBEAU
$991K 0.15%
+100,000
New +$999K
PNTM.U
177
DELISTED
Pontem Corporation Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
PNTM.U
$990K 0.15%
+100,000
New +$1.03M
IPVIU
178
DELISTED
InterPrivate IV InfraTech Partners Inc. Units
IPVIU
$990K 0.15%
+100,000
New +$997K
DNZ.U
179
DELISTED
D and Z Media Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-third of one Warrant
DNZ.U
$989K 0.15%
+100,000
New +$1.02M
IPVA.U
180
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
$989K 0.15%
+100,000
New +$997K
VOSOU
181
DELISTED
Virtuoso Acquisition Corp. Unit
VOSOU
$986K 0.15%
+100,000
New +$1.02M
IPVF.U
182
DELISTED
InterPrivate III Financial Partners Inc. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVF.U
$986K 0.15%
+100,000
New +$997K
CDTX
183
DELISTED
Cidara Therapeutics
CDTX
$982K 0.15%
18,455
TZPS
184
DELISTED
TZP Strategies Acquisition Corp. Class A Ordinary Share
TZPS
$971K 0.15%
+99,996
New +$978K
ADER
185
DELISTED
26 Capital Acquisition Corp
ADER
$970K 0.15%
+99,998
New +$976K
GSAQ
186
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$970K 0.15%
+99,998
New +$982K
MP.WS
187
DELISTED
MP Materials Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at
MP.WS
$967K 0.15%
40,000
-26,666
-40% -$630K
TLMD
188
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$944K 0.15%
150,000
-150,000
-50% -$1.13M
TME icon
189
Tencent Music
TME
$16.2B
$922K 0.14%
+45,000
New +$1.14M
LHDX
190
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$908K 0.14%
+75,000
New +$1.49M
RIDE
191
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$883K 0.14%
5,000
-25,000
-83% -$7.86M
LABP
192
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
$879K 0.14%
+9,131
New +$1.19M
DLCA
193
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
$879K 0.14%
+89,682
New +$877K
ACVA icon
194
ACV Auctions
ACVA
$1.27B
$865K 0.13%
+25,000
New +$800K
PRIM icon
195
Primoris Services
PRIM
$4.35B
$828K 0.13%
+25,000
New +$823K
EAC
196
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$824K 0.13%
+84,998
New +$829K
ARKOW
197
DELISTED
ARKO Corp Warrant
ARKOW
$812K 0.12%
396,295
+333,333
+529% +$588K
LASR icon
198
nLIGHT
LASR
$2.88B
$810K 0.12%
+25,000
New +$885K
VIRX
199
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$784K 0.12%
84,802
-14,762
-15% -$154K
KDMN
200
DELISTED
Kadmon Holdings, Inc.
KDMN
$778K 0.12%
+200,000
New +$916K

Similar funds

Monashee Investment Management's Q1 2021 Portfolio in Review

As of Q1 2021, Monashee Investment Management held 529 positions worth $650M, down 14% from $757M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Monashee Investment Management withdrew a net $73.7M in Q1 2021, closing 155 positions and reducing 22 holdings. Its most notable exit was Sigilon Therapeutics, Inc. Common Stock, an estimated $27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Beam Therapeutics worth $21.5M.

  • Monashee Investment Management's largest Q1 2021 buy was Beam Therapeutics: 268,820 shares worth $21.5M.
  • Monashee Investment Management added most to View, Inc. Class A Common Stock in Q1 2021, an estimated $11.9M increase.
  • Monashee Investment Management's biggest Q1 2021 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $53.1M.
  • Monashee Investment Management fully exited Sigilon Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $27M.
  • Monashee Investment Management's ten largest holdings make up 28% of its $650M portfolio in Q1 2021.
  • Monashee Investment Management opened 249 new positions and closed 155 in Q1 2021.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $650M.

Based on Monashee Investment Management's 13F filing for Q1 2021, filed 14 May 2021.